Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Rheumatology and Therapy
doi 10.1007/s40744-014-0005-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Work Productivity Improvement Associated With Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results of a Phase 3, Randomized, Controlled Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Case of Pityriasis Rubra Pilaris Treated Successfully With the Phosphodiesterase-4 Inhibitor Apremilast

Acta Dermato-Venereologica
DermatologyMedicine
2018English

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

A Comparison of Apremilast Monotherapy and Combination Therapy for Psoriatic Arthritis in a Real Life Setting: Data From the Leeds Combined Psoriatic Service

Journal of the American Academy of Dermatology
Dermatology
2019English

Pms50 - Cost-Effectiveness Analysis of Apremilast in the Treatment of Psoriatic Arthritis (Psa) in the Slovak Republic and Slovenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Treatment to Target in Psoriatic Arthritis With Apremilast: Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

Arthritis Care and Research
Rheumatology
2020English

Tofacitinib for the Treatment of Psoriasis and Psoriatic Arthritis

Expert Review of Clinical Immunology
AllergyImmunology
2018English

Pss13 - Budget Impact Analysis of Apremilast in Patients With Active Psoriatic Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost Per Responder of Apremilast Versus Etanercept and Adalimumab in Patients With Active Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy